Definium Therapeutics, Inc. - Common Shares, no par value per share (DFTX)

CUSIP: 24477V105

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+32,800,078
Put/Call ratio
40%
SEC-reported price per share
$47.04
Number of holders
356
Value change
+$1,632,500,660
Number of buys
257
Open additional details 1 more signal available
Number of sells
93
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
133,888,889

Security key

24477V105

Report period

Q2 2026

Institutions

356

Top holders

10

Ownership snapshot

Top reported holders of DFTX - Definium Therapeutics, Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
DRIEHAUS CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F 13D/G Lead comparable stake: 8.3% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 8.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 8.3%
DRIEHAUS CAPITAL MANAGEMENT LLC 5.4%
Avoro Capital Advisors LLC 5.1%
Deep Track Capital, LP 3%
Commodore Capital LP 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
8.3%
from 13D/G
$160,276,347
8,480,230 shares
31 Mar 2026
DRIEHAUS CAPITAL MANAGEMENT LLC
13D/G 13F
Company
5.4%
$298,796,297
6,845,276 shares
+$13,447,430 30 Jun 2026
Avoro Capital Advisors LLC
13F 13D/G
Company
5.1%
from 13D/G
$94,500,000
5,000,000 shares
31 Mar 2026
Deep Track Capital, LP
13D/G 13F
Company
3%
$66,750,000
3,000,000 shares
-$59,553,015 31 Mar 2026
Commodore Capital LP
13D/G 13F
Company
1.8%
$105,196,500
2,410,000 shares
-$219,069,529 30 Jun 2026
Janus Henderson Group Ltd.
13F
Company
13F
2.7%
$67,226,955
3,556,041 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
356
Shares
112,873,991
Rows available
356
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders
8
Q2 2026 holders
356
Holder diff
348
Investor Q4 2025 Shares Q2 2026 Shares Share Diff Share Chg % Q4 2025 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .